Food Allergy Treatment Market to Grow at a CAGR of 11.2% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Food Allergy Treatment Market?

The food allergy treatment market has experienced rapid expansion over recent years. This market is expected to increase from $6.82 billion in 2024 to $7.6 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.5%. The historical development of this market is due to factors such as the rising incidence of food allergies, an increase in regulatory approvals, the creation of emergency treatments, and enhanced investment in modern technologies.

The food allergy treatment market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $11.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.2%. Factors contributing to this growth during the forecast period include an expanding elderly population, a rise in food allergy diagnoses, increased healthcare expenditure, a surge in asthma cases, and a higher prevalence of food allergies. Key trends anticipated for the forecast period encompass significant innovation and technological progress, enhancements in medical technology and diagnostic methodologies, greater adoption of mobile applications and telemedicine services, an uptick in research and development initiatives, and a surge in new drug approvals and introductions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16684&type=smp

What Are The Drivers Pushing New Developments In The Food Allergy Treatment Market?

The rising prevalence of food adulteration is anticipated to stimulate the expansion of the food allergy treatment market in the future. Food adulteration involves the deliberate modification of food items by incorporating lower-quality, dangerous, or unapproved substances, or by extracting valuable components, to boost volume or improve aesthetic appeal, often at the cost of product quality and consumer safety. The increase in food adulteration stems from various elements, including financial incentives, intricate supply chains, insufficient regulatory oversight, technological developments, a push for convenience, globalization, environmental influences, consumer understanding, profit maximization goals, and inadequate enforcement of rules. This surge is predominantly fueled by a heightened consumer demand for more affordable goods, which prompts manufacturers to reduce expenses and maximize earnings through unethical methods. Such practices can elevate the potential for allergic responses by introducing allergens into food products or by undermining the safety and reliability of the food chain. For instance, in November 2022, Europol, a Netherlands-based government agency, reported that as part of Operation OPSON XI, coordinated by Europol, authorities in 26 countries seized nearly 27,000 tons of counterfeit food and 15 million liters of alcoholic beverages between December 2021 and May 2022. Consequently, the growing issue of food adulteration is propelling the development of the food allergy treatment market.

How Is The Food Allergy Treatment Market Classified Into Different Segments?

The food allergy treatmentmarket covered in this report is segmented –

1) By Drug Type: Antihistamines; Decongestants; Corticosteroids; Mast Cell Stabilizers; Leukotriene Inhibitors; Nasal Anti-Cholinergic; Immuno-Modulators; Epinephrine; Immunotherapy

2) By Route Of Administration: Parenteral; Oral

3) By Allergen Type: Dairy Products; Poultry Product; Tree Nuts; Peanuts; Shellfish; Wheat; Soys; Other Allergens

4) By End-Use: Hospital Pharmacies; Retail Pharmacies; Other End-Uses

Subsegments:

1) By Antihistamines: Oral Antihistamines; Topical Antihistamines; Intranasal Antihistamines

2) By Decongestants: Oral Decongestants; Nasal Decongestants

3) By Corticosteroids: Oral Corticosteroids; Topical Corticosteroids; Intranasal Corticosteroids

4) By Mast Cell Stabilizers: Cromolyn Sodium; Nedocromil

5) By Leukotriene Inhibitors: Montelukast; Zafirlukast

6) By Nasal Anti-Cholinergic: Ipratropium Bromide

7) By Immuno-Modulators: Omalizumab; Dupilumab

8) By Epinephrine: Injectable Epinephrine; Auto-Injectors

9) By Immunotherapy: Oral Immunotherapy (OIT); Sublingual Immunotherapy (SLIT); Epicutaneous Immunotherapy (EPIT)

Which Competitive Trends Are Defining The Food Allergy Treatment Market Structure?

Leading companies operating in the food allergy treatment market are advancing novel therapies, including monoclonal antibodies, to address the core mechanisms of food allergies and provide more effective solutions for patients. Monoclonal antibodies offer a promising approach for treating food allergies by specifically targeting components of the immune system implicated in allergic reactions, thus offering more precise and impactful treatments. For instance, in February 2024, Novartis AG, a pharmaceutical company based in Switzerland, secured FDA approval for Xolair (omalizumab) to alleviate IgE-mediated food allergies. This humanized monoclonal antibody is administered subcutaneously and operates by inhibiting the attachment of IgE antibodies, consequently reducing the release of chemicals responsible for allergy symptoms. The FDA approval was based on encouraging data from the Phase III OUtMATCH study, which revealed that a notably greater percentage of food allergy patients, including children as young as 1 year, treated with Xolair were able to tolerate small quantities of peanut, milk, egg, and cashews without an allergic response, compared to the placebo group.

Who Are The Top Performing Companies In The Food Allergy Treatment Market In Recent Years?

Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., Parexel International (MA) Corporation, Nestle Health Science, ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report

How Do Regional Market Performances Compare Within The Food Allergy Treatment Industry?

North America was the largest region in the food allergy treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Food Allergy Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16684&type=smp

Browse Through More Reports Similar to the Global Food Allergy Treatment Market 2025, By The Business Research Company

Perishable Prepared Food Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/perishable-prepared-food-global-market-report

Snack Food Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/snack-food-global-market-report

Frozen Food Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/frozen-food-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795